|
|||||
|
|
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma |
|
| Authors: | Osnat Bairey MD Alisa Taliansky MD Amir Glik MD Alexandra Amiel MD Shlomit Yust-Katz MD Ronit Gurion MD Miri Zektser MD Tzvika Porges MD Nadav Sarid MD Netanel A Horowitz MD Tzahala Tzuk Shina MD Eyal Lebel MD Amos Cohen MD Karyn Revital Geiger MD Pia Raanani MD Ofir Wolach MD Tali Siegal MD |
| Institution: | 1. Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel;2. Institute of Oncology, Neuro-Oncology Unit, Sheba Medical Center, Ramat Gan, Israel;3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Department of Neurology, Cognitive Neurology Clinic, Rabin Medical Center, Petach Tikva, Israel;4. Neuro-Oncology Center, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel;5. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Neuro-Oncology Center, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel;6. Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;7. Institute of Hematology, Soroka Medical Center, Beer-Sheva, Israel;8. Institute of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;9. Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel;10. Institute of Oncology, Neuro-Oncology Unit, Rambam Health Care Campus, Haifa, Israel;11. Department of Hematology, Hadassah Medical Center, Jerusalem, Israel Faculty of Medicine, Hebrew University, Jerusalem, Israel;12. Neuro-Oncology Center, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel Faculty of Medicine, Hebrew University, Jerusalem, Israel |
| Abstract: | |
| Keywords: | elderly ibrutinib maintenance treatment primary central nervous system lymphoma |